TrialArthritis & rheumatology (Hoboken, N.J.)2021

Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-Blind, Placebo-Controlled Trial.

Toby M Maher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.